首页> 外文期刊>Journal of the Association for Research in Otolaryngology: JARO >Heat Shock Protein-Mediated Protection Against Cisplatin-Induced Hair Cell Death
【24h】

Heat Shock Protein-Mediated Protection Against Cisplatin-Induced Hair Cell Death

机译:热休克蛋白介导的抗顺铂诱导的毛细胞死亡的保护

获取原文
获取原文并翻译 | 示例
       

摘要

Cisplatin is a highly successful and widely used chemotherapy for the treatment of various solid malignancies in both adult and pediatric patients. Side effects of cisplatin treatment include nephrotoxicity and ototoxicity. Cisplatin ototoxicity results from damage to and death of cells in the inner ear, including sensory hair cells. We showed previously that heat shock inhibits cisplatin-induced hair cell death in whole-organ cultures of utricles from adult mice. Since heat shock protein 70 (HSP70) is the most upregulated HSP in response to heat shock, we investigated the role of HSP70 as a potential protectant against cisplatin-induced hair cell death. Our data using utricles from HSP70 (-/-) mice indicate that HSP70 is necessary for the protective effect of heat shock against cisplatin-induced hair cell death. In addition, constitutive expression of inducible HSP70 offered modest protection against cisplatin-induced hair cell death. We also examined a second heat-inducible protein, heme oxygenase-1 (HO-1, also called HSP32). HO-1 is an enzyme responsible for the catabolism of free heme. We previously showed that induction of HO-1 using cobalt protoporphyrin IX (CoPPIX) inhibits aminoglycoside-induced hair cell death. Here, we show that HO-1 also offers significant protection against cisplatin-induced hair cell death. HO-1 induction occurred primarily in resident macrophages, with no detectable expression in hair cells or supporting cells. Depletion of macrophages from utricles abolished the protective effect of HO-1 induction. Together, our data indicate that HSP induction protects against cisplatin-induced hair cell death, and they suggest that resident macrophages mediate the protective effect of HO-1 induction.
机译:顺铂是一种非常成功且广泛使用的化学疗法,可用于治疗成人和小儿患者的各种实体恶性肿瘤。顺铂治疗的副作用包括肾毒性和耳毒性。顺铂耳毒性起因于内耳细胞(包括感觉毛细胞)的损坏和死亡。我们以前表明,热激抑制了成年小鼠全细胞培养物中顺铂诱导的毛细胞死亡。由于热激蛋白70(HSP70)是对热激反应最上调的HSP,因此我们研究了HSP70作为对抗顺铂引起的毛细胞死亡的潜在保护剂的作用。我们使用来自HSP70(-/-)小鼠尿囊的数据表明,HSP70对于热休克对顺铂诱导的毛细胞死亡的保护作用是必需的。此外,诱导型HSP70的组成型表达可有效抵抗顺铂诱导的毛细胞死亡。我们还检查了第二种热诱导蛋白,血红素加氧酶-1(HO-1,也称为HSP32)。 HO-1是负责游离血红素分解代谢的酶。我们以前表明使用钴原卟啉IX(CoPPIX)诱导HO-1可抑制氨基糖苷诱导的毛细胞死亡。在这里,我们表明HO-1还提供了针对顺铂诱导的毛细胞死亡的重要保护。 HO-1诱导主要发生在驻留的巨噬细胞中,在毛细胞或支持细胞中没有可检测到的表达。从细胞中清除巨噬细胞消除了HO-1诱导的保护作用。总之,我们的数据表明HSP诱导可防止顺铂诱导的毛细胞死亡,并且它们表明驻留的巨噬细胞介导HO-1诱导的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号